RCMF: a robust collaborative matrix factorization method to predict miRNA-disease associations

Predicting miRNA-disease associations (MDAs) is time-consuming and expensive. It is imminent to improve the accuracy of prediction results. So it is crucial to develop a novel computing technology to predict new MDAs. Although some existing methods can effectively predict novel MDAs, there are still some shortcomings. Especially when the disease matrix is processed, its sparsity is an important factor affecting the final results. A robust collaborative matrix factorization (RCMF) is proposed to predict novel MDAs. The L2,1-norm are introduced to our method to achieve the highest AUC value than other advanced methods. 5-fold cross validation is used to evaluate our method, and simulation experiments are used to predict novel associations on Gold Standard Dataset. Finally, our prediction accuracy is better than other existing advanced methods. Therefore, our approach is effective and feasible in predicting novel MDAs.

[1]  Ujjwal Maulik,et al.  Development of the human cancer microRNA network , 2010 .

[2]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[3]  Stefano Volinia,et al.  MicroRNA expression profiling in human Barrett's carcinogenesis , 2011, International journal of cancer.

[4]  Hiroshi Tanaka,et al.  Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. , 2012, Oncology letters.

[5]  Juan Wang,et al.  The computational prediction of drug-disease interactions using the dual-network L2,1-CMF method , 2018, BMC Bioinformatics.

[6]  Yan Zhao,et al.  ELLPMDA: Ensemble learning and link prediction for miRNA-disease association prediction , 2018, RNA biology.

[7]  Bin Liu,et al.  Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies a susceptibility locus at PLCE1 , 2010, Nature Genetics.

[8]  Qionghai Dai,et al.  WBSMDA: Within and Between Score for MiRNA-Disease Association prediction , 2016, Scientific Reports.

[9]  Hai-Cheng Yi,et al.  A Deep Learning Framework for Robust and Accurate Prediction of ncRNA-Protein Interactions Using Evolutionary Information , 2018, Molecular therapy. Nucleic acids.

[10]  Yufei Huang,et al.  Prediction of microRNAs Associated with Human Diseases Based on Weighted k Most Similar Neighbors , 2013, PloS one.

[11]  V. Ambros.  microRNAs Tiny Regulators with Great Potential , 2001, Cell.

[12]  Xing Chen,et al.  HAMDA: Hybrid Approach for MiRNA-Disease Association prediction , 2017, J. Biomed. Informatics.

[13]  Xing Chen,et al.  RKNNMDA: Ranking-based KNN for MiRNA-Disease Association prediction , 2017, RNA biology.

[14]  Zhen Cui,et al.  LncRNA-Disease Associations Prediction Using Bipartite Local Model With Nearest Profile-Based Association Inferring , 2020, IEEE Journal of Biomedical and Health Informatics.

[15]  Chee Keong Kwoh,et al.  Drug-target interaction prediction via class imbalance-aware ensemble learning , 2016, BMC Bioinformatics.

[16]  De-Shuang Huang,et al.  Novel human microbe-disease association prediction using network consistency projection , 2017, BMC Bioinformatics.

[17]  Kyungsook Han,et al.  miRNA-Disease Association Prediction with Collaborative Matrix Factorization , 2017, Complex..

[18]  Xiangxiang Zeng,et al.  Inferring MicroRNA-Disease Associations by Random Walk on a Heterogeneous Network with Multiple Data Sources , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[19]  P. Igarashi,et al.  miR-17∼92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease , 2013, Proceedings of the National Academy of Sciences.

[20]  Chun-Hou Zheng,et al.  Identifying drug-pathway association pairs based on L2,1-integrative penalized matrix decomposition , 2017, BMC Systems Biology.

[21]  Zhen Cui,et al.  LWPCMF: Logistic Weighted Profile-Based Collaborative Matrix Factorization for Predicting MiRNA-Disease Associations , 2019, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[22]  David I. Smith,et al.  Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas , 2002, Oncogene.

[23]  Motohiro Kojima,et al.  MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers , 2015, PloS one.

[24]  Rong Zhu,et al.  Co-differential Gene Selection and Clustering Based on Graph Regularized Multi-View NMF in Cancer Genomic Data , 2018, Genes.

[25]  Mohamed A. Ismail,et al.  miRNA and gene expression based cancer classification using self-learning and co-training approaches , 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine.

[26]  Bo Liu,et al.  Down-regulated miR-9 and miR-433 in human gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[27]  Xing Chen,et al.  RWRMDA: predicting novel human microRNA-disease associations. , 2012, Molecular bioSystems.

[28]  Jin-Xing Liu,et al.  L2,1-GRMF: an improved graph regularized matrix factorization method to predict drug-target interactions , 2019, BMC Bioinformatics.

[29]  Xing Chen,et al.  MKRMDA: multiple kernel learning-based Kronecker regularized least squares for MiRNA–disease association prediction , 2017, Journal of Translational Medicine.

[30]  Chee-Keong Kwoh,et al.  Computational prediction of drug-target interactions using chemogenomic approaches: an empirical survey , 2019, Briefings Bioinform..

[31]  B. Reinhart,et al.  The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans , 2000, Nature.

[32]  Xing Chen,et al.  HGIMDA: Heterogeneous graph inference for miRNA-disease association prediction , 2016, Oncotarget.

[33]  V. Ambros,et al.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 , 1993, Cell.

[34]  Xing Chen,et al.  Semi-supervised learning for potential human microRNA-disease associations inference , 2014, Scientific Reports.

[35]  Yadong Wang,et al.  Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.

[36]  Chun-Hou Zheng,et al.  NPCMF: Nearest Profile-based Collaborative Matrix Factorization method for predicting miRNA-disease associations , 2019, BMC Bioinformatics.

[37]  Zhaolei Zhang,et al.  Evidence for Positive Selection on a Number of MicroRNA Regulatory Interactions during Recent Human Evolution , 2012, PLoS genetics.

[38]  Feng Li,et al.  Dual Sparse Collaborative Matrix Factorization Method Based on Gaussian Kernel Function for Predicting LncRNA-Disease Associations , 2019, ICIC.

[39]  Chen Peng,et al.  Discovery of Relationships Between Long Non-Coding RNAs and Genes in Human Diseases Based on Tensor Completion , 2018, IEEE Access.

[40]  Chun-Hou Zheng,et al.  Dual-network sparse graph regularized matrix factorization for predicting miRNA-disease associations. , 2019, Molecular omics.

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  Xiaobo Zhou,et al.  Nonconvex Penalty Based Low-Rank Representation and Sparse Regression for eQTL Mapping , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[43]  Changning Liu,et al.  dbDEMC: a database of differentially expressed miRNAs in human cancers , 2010, BMC Genomics.

[44]  Dong Wang,et al.  Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases , 2010, Bioinform..

[45]  Xia Li,et al.  Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes , 2013, BMC Systems Biology.

[46]  Chee Keong Kwoh,et al.  Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[47]  T. Tuschl,et al.  Mechanisms of gene silencing by double-stranded RNA , 2004, Nature.

[48]  Lei Zhang,et al.  Tumor Clustering Using Nonnegative Matrix Factorization With Gene Selection , 2009, IEEE Transactions on Information Technology in Biomedicine.

[49]  De-Shuang Huang,et al.  Independent component analysis-based penalized discriminant method for tumor classification using gene expression data , 2006, Bioinform..

[50]  Hyun Goo Woo,et al.  Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma , 2012, Hepatology.

[51]  Praveen Sethupathy,et al.  MicroRNA target site polymorphisms and human disease. , 2008, Trends in genetics : TIG.

[52]  Jin-Xing Liu,et al.  Hypergraph regularized NMF by L2,1-norm for Clustering and Com-abnormal Expression Genes Selection , 2018, 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[53]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[54]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[55]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[56]  Yue Hu,et al.  Differentially Expressed Genes Extracted by the Tensor Robust Principal Component Analysis (TRPCA) Method , 2019, Complex..

[57]  De-Shuang Huang,et al.  Mining the bladder cancer-associated genes by an integrated strategy for the construction and analysis of differential co-expression networks , 2015, BMC Genomics.